Alan M. Fogelman
Alan M. Fogelman publishes mostly in Molecular Biology, Surgery and Immunology, on topics such as Lipoproteins and Cardiovascular Health, Cholesterol and Lipid Metabolism and Paraoxonase enzyme and polymorphisms.
- World rank
- #18,654 of 7,710,434 ranked researchers
- Rank in United States
- #6,720 of 1,627,098
- Works
- 343
- Citations
- 40k
- Citations per work
- 116.0
What does Alan M. Fogelman research?
Alan M. Fogelman's work is mostly in Biochemistry, Genetics and Molecular Biology (28%), Medicine (23%), Immunology and Microbiology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else13740.0%
- Life Sciences12636.7%
- Health Sciences8023.3%
- Medicine8023.3%
- 1Molecular Biology15% of their works
- 2Surgery15% of their works
- 3Immunology9% of their works
- 4Endocrinology, Diabetes and Metabolism8% of their works
- 5Clinical Biochemistry7% of their works
- 6Cancer Research6% of their works
Research topics
- Lipoproteins and Cardiovascular Health
- Cholesterol and Lipid Metabolism
- Paraoxonase enzyme and polymorphisms
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Atherosclerosis and Cardiovascular Diseases
- Cancer, Lipids, and Metabolism
- Antioxidant Activity and Oxidative Stress
- Peroxisome Proliferator-Activated Receptors
Which keywords describe Alan M. Fogelman's research?
The keywords of their largest research topics: Atherosclerosis, Inflammation, Cholesterol, HDL, Cardiovascular Disease, Statins, Lipid Peroxidation and Oxidative Stress.
- PPARs
- Antioxidants
- Fatty Acid Synthase
- Immune Response
- Insulin Resistance
- Antioxidant
- LXR
- Cardiovascular Disease Prevention
- Diabetes
- Oxidative Stress
- Statins
- HDL
- Inflammation
- Atherosclerosis
- Cholesterol
- Cardiovascular Disease
- Lipid Peroxidation
- Metabolism
- Obesity
- Cholesterol-lowering
- SREBP
- Paraoxonase
- Metabolic Syndrome
- Oxidized LDL
- Lipid Metabolism
- Carotenoids
- Peroxisome Proliferator-Activated Receptors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 27 words, with their numbers
- Atherosclerosis2795 topics
- Inflammation1884 topics
- Cholesterol1663 topics
- HDL1242 topics
- Cardiovascular Disease1192 topics
- Statins1072 topics
- Lipid Peroxidation1002 topics
- Oxidative Stress1002 topics
- Metabolism962 topics
- Diabetes912 topics
- Obesity912 topics
- Cardiovascular Disease Prevention641 topic
- Cholesterol-lowering641 topic
- LXR641 topic
- SREBP641 topic
- Antioxidant601 topic
- Paraoxonase601 topic
- Insulin Resistance591 topic
- Metabolic Syndrome591 topic
- Immune Response561 topic
- Oxidized LDL561 topic
- Fatty Acid Synthase431 topic
- Lipid Metabolism431 topic
- Antioxidants401 topic
- Carotenoids401 topic
- PPARs321 topic
- Peroxisome Proliferator-Activated Receptors321 topic
Where does Alan M. Fogelman work?
Alan M. Fogelman's main affiliation in the publication record is University of California, Los Angeles, United States.
How many publications and citations does Alan M. Fogelman have?
OpenAlex counts 343 works and 39,805 citations for Alan M. Fogelman, an h-index of 103, ranking #18,654 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Alan M. Fogelman. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.